what is the best type of l-carnitine Doctors Fumarate How to Choose the Best
Description
doi: 10.1056/NEJMoa2024816 Summary Keywords advances, kidney disease, pathogenesis, therapy, APOL1 gene Citation Boima V, Agyekum AB, Ganatra K, Agyekum F, Kwakyi E, Inusah J, Ametefe EN and Adu D (2025) Advances in kidney disease: pathogenesis and therapeutic targets
Available at Updated 02/27/2023
These data point to calpain inhibition as potential early target to prevent enhanced sensitivity to NMDA as well as prevent p38 activation in later disease stages (Gladding et al
Zhu, & R
